Pharmacotherapy for Obesity | July 2021-Recorded Webinar

Video Transcription

Video Summary

The webinar discussed pharmacotherapy for obesity, focusing on medications that assist with weight loss. The presenter mentioned various medications such as phentermine, topiramate, bupropion naltrexone, SGLT2 inhibitors, GLP-1 receptor agonists, and metformin. They explained the mechanisms of action, dosing, side effects, contraindications, and potential benefits of these medications. The presenter also emphasized the importance of a personalized approach to diet and exercise, as there is no one-size-fits-all diet that is best for everyone. They also mentioned the potential for weight regain after stopping medication use and highlighted the need for long-term, chronic use of these medications, similar to other chronic disease medications. The webinar provided data from studies and trials that support the use of these medications for weight loss. The presenter concluded by encouraging ongoing research in the field and the need for individualized treatment plans for patients with obesity. The webinar was presented by Dr. Anthony Millard with the Association for Bariatric Endoscopy.

Keywords

pharmacotherapy

obesity

weight loss

medications

phentermine

topiramate

bupropion naltrexone

SGLT2 inhibitors

GLP-1 receptor agonists

metformin